Recall events
/
Event 88598
Event summary
Timeline bucket September 01, 2021
Product types Drug
Classifications Class III
Statuses Terminated
Recalling firm wording Monarch PCM, LLC
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Sodium Sulfacetamide, 10%, Wash, packaged in bottles: a) 6 fl oz (177 mL) NDC 42808-103-06 UPC 3 42808 10306 5; b) 12 fl oz (354.8 mL) NDC 42808-103-12 UPC 3 42808 10312 6, Rx only, Manufactured in the U.S.A. for Exact-Rx, Inc., Melville, NY 11747
D-0817-2021
Recall number D-0817-2021
Initiated September 01, 2021
Classification Class III
Status Terminated
Quantity a) 3305 bottles; b) 840 bottles
App-derived interpretation
Potency or specification failure
reason.potency_specification_failure · v1.0.0
Subpotency
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Subpotency: one product for active ingredient assay and another one for preservative assay
Code information Lots: a) 21FP1737 Exp 05/2023; b) 21FP1738 Exp 05/2023
Distribution pattern OH, TN
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[17061]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
Hydroquinone, USP, 4% Skin Bleaching Cream, packaged in 1 oz (28.35g) tube, Rx only, Manufactured for: Westminster Pharmaceuticals, LLC Nashville, TN 37217, NDC 69367-174-01 UPC 3 69367 17401 5
D-0818-2021
Recall number D-0818-2021
Initiated September 01, 2021
Classification Class III
Status Terminated
Quantity 6305 tubes
App-derived interpretation
Potency or specification failure
reason.potency_specification_failure · v1.0.0
Subpotency
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Subpotency: one product for active ingredient assay and another one for preservative assay
Code information Lot: 21FP1731 Exp 05/2023
Distribution pattern OH, TN
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5172]
FDA event record
· Exact recall-number query on openFDA